FdaApplication
ANDA 213796
Identifiers
- fda_app_no: ANDA213796
Properties
| Property | Value |
|---|---|
| applicant_name | ADAPTIS PHARMA PRIVATE LTD |
| application_type | ANDA |
| approval_date | 2022-04-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | EQ 150MG BASE | CAPSULE;ORAL |
1 product